Immunization

Robert Hopkins, chair of the National Vaccine Advisory Committee, discusses the most pressing issues coming out of the recent NVAC meeting, and pharmacy's role amid the COVID-19 pandemic.

CMS’ new plan will ensure coverage of COVID-19 vaccines with no out-of-pocket costs, while increasing the number of providers that will administer the vaccine.

Study suggests review of current recommendations.

Of the nearly 3 million Americans included in the study, just 1.4% had the flu vaccine and 1.4% had the pneumonia vaccine.

The program is designed to prepare state-licensed pharmacists to meet requirements for administering vaccinations to pediatric patients.

A poster at the virtual 2020 ID Week looked at how vaccine type can impact diphtheria, tetanus, and acellular pertussis (DTaP) vaccination.

Investigators stressed that governments, public health officials, and other non-governmental organizations should aim to build trust in a COVID-19 vaccine.

Here's the coronavirus-related news from this week that you should know.

The combined landscape of flu and COVID-19 presents challenges to vaccine uptake.

The new guidance provides clarification on requirements for pharmacy interns and technicians to administer childhood and COVID-vaccines, as well as COVID-19 tests.

In an open letter, Pfizer Chairman and CEO wrote that safety and efficacy data for its COVID-19 vaccine candidate may be ready by the third week of November for FDA submission.

The BCG vaccine decreased the overall risk of new respiratory infections in elderly adults, according to the study results.

A new report from the National Academies of Sciences, Engineering, and Medicine include pharmacists in the priority group for receiving the COVID-19 vaccine when available.

Amid this unprecedented flu season, experts recommend co-administering flu and shingles vaccines.

Moderna’s COVID-19 mRNA vaccine candidate appears to induce as strong an immune response in older adults as in younger adults, according to an interim analysis.

The report contains new recommendations for the administration of booster doses of serogroup B meningococcal vaccine for those at increased risk of the disease.

Approximately 1-third of parents who participated in a national survey said they are unlikely to have their child vaccinated against the flu amid the pandemic.

Anticipating higher demand for the flu vaccine this season, many pharmacy chains are expanding their services.

A recent report looked at whether human papilloma virus (HPV) vaccination coverage will meet the Healthy People 2020 goal.

Johnson & Johnson has launched its large-scale phase 3 trial for Janssen’s COVID-19 vaccine candidate.

The Trump administration released its COVID-19 vaccine strategy, with pharmacies among the list of suggested providers for distribution.

Survey responses indicated that almost 7 in 10 Americans are willing to get a COVID-19 vaccine when it becomes available.

After a temporary pause, investigators have received the green light to resume clinical trials for COVID-19 vaccine candidate AZD1222 following a safety review.

Albertsons announced its pharmacies will begin to offer vaccinations to children 3 years and older nationwide.

State-licensed pharmacists and pharmacy interns will be able to order and administer coronavirus disease 2019 vaccines under certain conditions.